This week, a monoclonal antibody cocktail cut COVID-19 hospitalization and death by 70% in an outpatient setting; removing race correction in lung function tests shows more severe disease in Black patients; gefapixant reduces chronic cough frequency in a large pooled analysis; daily probiotics reduced upper respiratory tract infection symptoms; and moderate alcohol intake lowers stress-related brain activity and may reduce CVD risk.

Read the full coverage here:

Monoclonal antibody cocktail cut COVID-19 hospitalization, death by 70% in outpatient setting

Removing race correction in lung function tests shows more severe disease in Black patients

Gefapixant reduces chronic cough frequency in large pooled analysis

Probiotics, reduction in upper respiratory tract infection symptoms

Moderate alcohol intake lowers stress-related brain activity, may reduce CVD risk